Treatment which could prevent wound scarring to be presented
Research at our University has revealed a potential treatment to prevent wound scarring that will soon be entering clinical trials.
Professor Christine Pullar from the University’s Department of Molecular and Cell Biology will discuss her research which has shown that Salbutamol, a safe and well-tolerated pharmaceutical, curbs excessive cell behaviour and moves the healing process towards normal skin regeneration in an upcoming Professorial Inaugural Lecture.
The lecture, titled 'Old dogs for new tricks: The use of Salbutamol to regenerate skin, reducing skin wound fibrosis/scars’, is part of the Professorial Inaugural lecture Series at the University of Leicester. It takes place on Thursday 22 June at 12pm in the Frank and Katherine May Lecture Theatre, Henry Wellcome Building and is free and open to the public. Book your place here.
There are currently no proven treatments available to prevent wound scarring. Salbutamol has been used in asthma therapy in the UK since 1968 and could deliver a clinical and cost-effective solution to wound scarring. Professor Pullar’s patented anti-scar treatment has passed all pre-clinical safety assessments and human clinical trials will begin in October 2017.
The research conducted into the use of salbutamol to regenerate skill and reduce skin fibrosis has been nominated for a Research Impact Award at the University of Leicester for best potential economic impact.